Amyloidosis is an extracellular mesenchymal dysproteinosis characterized by deposition of amyloid in tissues, parenchymal atrophy and functional organ failure leading to fatal outcomes. A significant problem of this disease for a doctor of any specialty remains a long period of establishing a clinical diagnosis. Insufficient awareness of the disease, due, among other things, to the extremely low incidence of patients with amyloidosis — today about 50 thousand people suffer from amyloidosis in the world. The article presents a clinical case of the early stage of primary systemic AL-amyloidosis affecting the eyelid skin bilaterally with further disease progression involving the skin of palms, soles and the oral mucosa. Among the types of amyloidosis described so far, the ocular adnexal involvement is an extremely rare finding which has such manifestations as periorbital cutaneous purpura and ecchymoses — “racoon eyes.” Timely diagnosis, the selection of individualized treatment strategies and the administration of chemotherapy would ensure clinical and hematological remission of amyloidosis, halt the disease progression, and thus reduce the probability of adverse outcome. The described clinical case has demonstrated that diagnosis of amyloidosis can be challenging, and that the disease has diverse and non-specific clinical manifestations. Keywords: amyloidosis, periorbital purpura, cutaneous ecchymoses, racoon, eyes, orbital amyloidosis, ocular adnexal amyloidosis, chemotherapy. For citation: Bochkareva A.N., Egorov V.V., Kolenko O.V. et al. Cutaneous amyloidosis in the orbital region (case report). Russian Journal of Clinical Ophthalmology. 2023;23(2):94–98 (in Russ.). DOI: 10.32364/2311-7729-2023-23-2-94-98.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.